ENP — Entropy Neurodynamics Share News
0.000.00%
Last trade - 00:00- AU$52.13m
- AU$46.56m
- AU$2.06m
Brief: Exopharm Says Received Firm Commitments To Raise $12 Mln
Australia Stock Exchange release from EXOPHARM LIMITED : Proposed issue of Securities - EX1
Australia Stock Exchange release from EXOPHARM LIMITED : Exopharm Receives Firm Commitments to Raise $12 million
Australia Stock Exchange release from EXOPHARM LIMITED : PRE_NR Ends: 09:50:23
Australia Stock Exchange release from EXOPHARM LIMITED : Investor Presentation - Delivering Transformative Medicines
Australia Stock Exchange release from EXOPHARM LIMITED : Trading Halt Remains
Australia Stock Exchange release from EXOPHARM LIMITED : Quarterly Activities Report and Appendix 4C
Brief: Exopharm Seeks Trading Halt
Australia Stock Exchange release from EXOPHARM LIMITED : Trading Halt
Brief: Exopharm Promotes Chris Baldwin As Deputy CEO In Addition To CCO Role
Australia Stock Exchange release from EXOPHARM LIMITED : Exopharm Shareholder Update - Revenue Focus in 2021
Australia Stock Exchange release from EXOPHARM LIMITED : Appendix 3G
Brief: Exopharm Announces Non-Binding HOA With Finnish Red Cross Blood Service
Australia's Exopharm jumps on potential commercial licensing deal
Brief: Exopharm Updates on Results From Plexoval II Phase I Safety Study With Plexaris
Australia Stock Exchange release from EXOPHARM LIMITED : LEAP Technology- Advanced EV Medicines from Blood Components
Australia Stock Exchange release from EXOPHARM LIMITED : PRE_NR Ends: 08:32:38
Australia Stock Exchange release from EXOPHARM LIMITED : Positive PLEXOVAL II Phase 1 Clinical Trial Results
Australia Stock Exchange release from EXOPHARM LIMITED : Securities Trading Policy